CLINICIAN REVIEWEDEVIDENCE-BASED

Multiple sclerosis

Multiple sclerosis (MS) is a condition of the central nervous system that affects the brain and spinal cord. Symptoms vary widely and may include visual problems, numbness, weakness, balance problems, fatigue and cognitive changes.

At a glance

Quick facts

Condition snapshot
Category
Chronic central nervous system disease
Main systems
Brain · spinal cord · optic nerves
Course
Relapsing and/or progressive patterns
Diagnosis
Neurologic assessment + MRI
Global average diagnosis age
32 years (Atlas of MS 2020)
Treatment
Disease modification + symptom care
Medically reviewed

Dr. Fitsum Admasu Tinsae

General Medicine · Public Health · Digital Health

Reviewed for clinical accuracy, clarity and practical public-health context.

Names & terminology

How this entity may be named or searched

Canonical name
Multiple sclerosis
Abbreviation
MS
Historical term
Disseminated sclerosis appears in older literature and is not the preferred modern name.
Related concepts
Clinically isolated syndrome and radiologically isolated syndrome are related diagnostic concepts, not simple synonyms.

Structured entity profile

Clinical profile

Condition data
ClassificationChronic central nervous system diseaseMS affects the brain, spinal cord and optic nerves.
Core processImmune-mediated damageInflammation damages myelin and can affect nerve fibres.
Key systemsVision · sensation · movement · cognitionSymptoms depend on lesion location and disease activity.
TransmissionNot contagiousMS is not an infectious disease.
CourseVariableRelapsing and progressive patterns are recognized.
DiagnosisNeurologic assessment + MRINo single test diagnoses every case; mimics must be excluded.
Typical diagnosis ageYoung to mid-adulthoodAtlas of MS reported a global average diagnosis age of 32 years.
Treatment goalReduce disease activity and disabilityDisease-modifying therapy, relapse care, symptom treatment and rehabilitation can all contribute.

What is multiple sclerosis?

Multiple sclerosis is a condition affecting the brain and spinal cord. It can cause a wide range of neurological symptoms, and the pattern can include relapses and remissions or gradual progression. There is no single symptom pattern that fits everyone. [1]

Symptoms

Possible symptoms include fatigue, visual disturbance or eye pain, numbness or tingling, weakness, balance or coordination problems, muscle stiffness or spasms, bladder symptoms and problems with memory or concentration. These symptoms are not specific to MS and can have other causes. [1]

SYMPTOM MATRIX

How multiple sclerosis may present

Symptoms can appear in many combinations and may come and go or progress over time.

Scan by urgency
Common
  • Fatigue
  • Visual disturbance
  • Numbness or tingling
  • Weakness
  • Balance or coordination problems
Can also occur
  • Muscle stiffness or spasms
  • Bladder or bowel symptoms
  • Pain
  • Cognitive changes
  • Mood or sleep problems
Urgent assessment
  • Sudden major loss of vision
  • New severe weakness
  • New inability to walk
  • Acute neurologic symptoms with impaired consciousness

New or rapidly worsening neurologic symptoms need clinical assessment; not every symptom change represents an MS relapse.

Diagnosis

MS is diagnosed by a neurologist using a combination of history, neurological examination, MRI and laboratory findings. NICE’s 2026 update points clinicians to the revised 2024 McDonald criteria. There is no single standalone test that establishes MS in every case. [1] [2]

1 expert note

MRI is a key investigation in multiple sclerosis, but it is interpreted together with the neurological history, examination and other evidence rather than used as a stand-alone diagnosis.

Diagnostic pathway

How multiple sclerosis is diagnosed

Neurologists combine clinical history, examination and evidence from MRI and sometimes cerebrospinal fluid or laboratory testing.

Clinical assessment
1Neurologic historyEpisodes, timing and neurologic symptom patterns are reviewed.
2ExaminationVision, strength, sensation, coordination, reflexes and gait are assessed.
3MRIBrain and/or spinal MRI looks for lesions typical of demyelination.
4Additional testsCSF and blood tests may support diagnosis or help exclude mimics.
5Apply diagnostic criteriaEvidence is integrated using current McDonald criteria and the clinical context.

MS diagnosis requires specialist interpretation; there is no single stand-alone screening test.

Treatment

Treatment depends on the type of MS, disease activity and symptoms. It may include disease-modifying therapies to reduce relapses or progression, corticosteroids for selected relapses, and treatments for symptoms such as spasticity, pain, bladder problems or fatigue. Rehabilitation and multidisciplinary support are often important. [1] [2]

1 expert note

There is currently no cure for multiple sclerosis, but treatment can reduce relapses, slow disease activity or progression in appropriate patients, and help manage symptoms and quality of life.

Treatment & care hub

MS care combines disease modification, relapse care and rehabilitation

Treatment depends on disease course, activity, symptoms, comorbidities, pregnancy plans and individual preferences.

Care pathways
Disease-modifying therapyLong-term disease control

Disease-modifying therapy

DMTs aim to reduce relapses and/or new disease activity; selection is individualized.

Relapse treatmentShort-term

Relapse treatment

Corticosteroids may be used for selected clinically significant relapses.

Symptom managementFunction & comfort

Symptom management

Spasticity, pain, bladder symptoms, fatigue and mood may require targeted treatment.

Rehabilitation & supportMultidisciplinary

Rehabilitation & support

Physiotherapy, occupational therapy, cognitive support and social care can help maintain function.

Treatment choices require specialist assessment and ongoing monitoring.

Living with MS

People with MS may need different kinds of support over time, including physiotherapy, occupational therapy, mobility aids, fatigue management, cognitive rehabilitation and psychological support. Care is usually individualized and reviewed as needs change. [1]

Geo data · Atlas of MS

Multiple sclerosis around the world

The main tabs compare the same epidemiologic concept: people living with MS. Country resource data are kept outside the comparison when a national MS count is unavailable.

Atlas of MS ↗
People living with MS3.1Mlatest Atlas estimate · 2024
Global prevalence38 per 100,000
Global average diagnosis age32 years
TrendEstimated burden increasing
Country data availability
South Africa

MS specialist neurologists

20
Health-system resource

Atlas of MS country factsheet; national number of people with MS is not available in the current factsheet.

Atlas of MS ↗
Data availability: main tabs use population-burden estimates. South Africa is shown separately because the Atlas currently exposes specialist-resource data rather than a national MS count.

Common questions

1 expert note

A relapse means new or worsening neurological symptoms lasting more than 24 hours after a stable period, with infection and other explanations considered and excluded where appropriate.

Frequently asked questions

Reference content

Sources

Clinical statements in this reference are linked to named public-health, regulatory or guideline sources.

  1. 1. NHS. Multiple sclerosis — symptoms, diagnosis and treatment. Source ↗
  2. 2. NICE. Multiple sclerosis in adults: management (NG220), updated June 2026. Source ↗
  3. 3. MS International Federation. Atlas of MS 2020 — epidemiology report. Source ↗
  4. 4. MS International Federation. Atlas of MS — latest global and country epidemiology / clinical-management data. Source ↗

This article is based on trusted medical sources and has undergone clinician review. It is not a substitute for personalized medical advice.